Cavb3 Citations (15)

Originally described in: Cavb3
Unpublished

---

Articles Citing Cavb3

Articles
Spinal morphine but not ziconotide or gabapentin analgesia is affected by alternative splicing of voltage-gated calcium channel CaV2.2 pre-mRNA. Jiang YQ, Andrade A, Lipscombe D. Mol Pain. 2013 Dec 26;9:67. doi: 10.1186/1744-8069-9-67. PubMed
Electrical coupling between the human serotonin transporter and voltage-gated Ca(2+) channels. Ruchala I, Cabra V, Solis E Jr, Glennon RA, De Felice LJ, Eltit JM. Cell Calcium. 2014 Jul;56(1):25-33. doi: 10.1016/j.ceca.2014.04.003. Epub 2014 Apr 27. PubMed
Amphetamine activates calcium channels through dopamine transporter-mediated depolarization. Cameron KN, Solis E Jr, Ruchala I, De Felice LJ, Eltit JM. Cell Calcium. 2015 Jul 2. pii: S0143-4160(15)00116-5. doi: 10.1016/j.ceca.2015.06.013. PubMed
Heparin/heparan sulfates bind to and modulate neuronal L-type (Cav1.2) voltage-dependent Ca(2+) channels. Garau G, Magotti P, Heine M, Korotchenko S, Lievens PM, Berezin V, Dityatev A. Exp Neurol. 2015 Dec;274(Pt B):156-65. doi: 10.1016/j.expneurol.2015.08.006. Epub 2015 Aug 10. PubMed
Molecular basis of ancestral vertebrate electroreception. Bellono NW, Leitch DB, Julius D. Nature. 2017 Mar 16;543(7645):391-396. doi: 10.1038/nature21401. Epub 2017 Mar 6. PubMed
Neuronal calcium channel alpha1 subunit interacts with AMPA receptor, increasing its cell surface localisation. Seo BA, Lee JH, Kim HM, Kang MG. Biochem Biophys Res Commun. 2018 Apr 6;498(3):402-408. doi: 10.1016/j.bbrc.2018.02.107. Epub 2018 Feb 12. PubMed
A Critical Neurodevelopmental Role for L-Type Voltage-Gated Calcium Channels in Neurite Extension and Radial Migration. Kamijo S, Ishii Y, Horigane SI, Suzuki K, Ohkura M, Nakai J, Fujii H, Takemoto-Kimura S, Bito H. J Neurosci. 2018 Jun 13;38(24):5551-5566. doi: 10.1523/JNEUROSCI.2357-17.2018. Epub 2018 May 17. PubMed
Expression of voltage-gated calcium channels augments cell susceptibility to membrane disruption by nanosecond pulsed electric field. Hristov K, Mangalanathan U, Casciola M, Pakhomova ON, Pakhomov AG. Biochim Biophys Acta Biomembr. 2018 Nov;1860(11):2175-2183. doi: 10.1016/j.bbamem.2018.08.017. Epub 2018 Sep 1. PubMed
TAT-Modified omega-Conotoxin MVIIA for Crossing the Blood-Brain Barrier. Yu S, Li Y, Chen J, Zhang Y, Tao X, Dai Q, Wang Y, Li S, Dong M. Mar Drugs. 2019 May 12;17(5). pii: md17050286. doi: 10.3390/md17050286. PubMed
Transient Confinement of CaV2.1 Ca(2+)-Channel Splice Variants Shapes Synaptic Short-Term Plasticity. Heck J, Parutto P, Ciuraszkiewicz A, Bikbaev A, Freund R, Mitlohner J, Andres-Alonso M, Fejtova A, Holcman D, Heine M. Neuron. 2019 Jul 3;103(1):66-79.e12. doi: 10.1016/j.neuron.2019.04.030. Epub 2019 May 16. PubMed
Both gain-of-function and loss-of-function de novo CACNA1A mutations cause severe developmental epileptic encephalopathies in the spectrum of Lennox-Gastaut syndrome. Jiang X, Raju PK, D'Avanzo N, Lachance M, Pepin J, Dubeau F, Mitchell WG, Bello-Espinosa LE, Pierson TM, Minassian BA, Lacaille JC, Rossignol E. Epilepsia. 2019 Sep;60(9):1881-1894. doi: 10.1111/epi.16316. Epub 2019 Aug 29. PubMed
Kv2.1 mediates spatial and functional coupling of L-type calcium channels and ryanodine receptors in mammalian neurons. Vierra NC, Kirmiz M, van der List D, Santana LF, Trimmer JS. Elife. 2019 Oct 30;8. pii: 49953. doi: 10.7554/eLife.49953. PubMed
Disruption of Cav1.2-mediated signaling is a pathway for ketamine-induced pathology. Chen H, Vandorpe DH, Xie X, Alper SL, Zeidel ML, Yu W. Nat Commun. 2020 Aug 28;11(1):4328. doi: 10.1038/s41467-020-18167-4. PubMed
A high-affinity, partial antagonist effect of 3,4-diaminopyridine mediates action potential broadening and enhancement of transmitter release at NMJs. Ojala KS, Ginebaugh SP, Wu M, Miller EW, Ortiz G, Covarrubias M, Meriney SD. J Biol Chem. 2021 Jan-Jun;296:100302. doi: 10.1016/j.jbc.2021.100302. Epub 2021 Jan 17. PubMed
Phenotypic expansion of CACNA1C-associated disorders to include isolated neurological manifestations. Rodan LH, Spillmann RC, Kurata HT, Lamothe SM, Maghera J, Jamra RA, Alkelai A, Antonarakis SE, Atallah I, Bar-Yosef O, Bilan F, Bjorgo K, Blanc X, Van Bogaert P, Bolkier Y, Burrage LC, Christ BU, Granadillo JL, Dickson P, Donald KA, Dubourg C, Eliyahu A, Emrick L, Engleman K, Gonfiantini MV, Good JM, Kalser J, Kloeckner C, Lachmeijer G, Macchiaiolo M, Nicita F, Odent S, O'Heir E, Ortiz-Gonzalez X, Pacio-Miguez M, Palomares-Bralo M, Pena L, Platzer K, Quinodoz M, Ranza E, Rosenfeld JA, Roulet-Perez E, Santani A, Santos-Simarro F, Pode-Shakked B, Skraban C, Slaugh R, Superti-Furga A, Thiffault I, van Jaabrsveld RH, Vincent M, Wang HG, Zacher P, Rush E, Pitt GS, Au PYB, Shashi V. Genet Med. 2021 Oct;23(10):1922-1932. doi: 10.1038/s41436-021-01232-8. Epub 2021 Jun 23. PubMed

If you have published an article using this material, please email us at to have your article added to this page.